BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32242518)

  • 1. Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial.
    Gruner LF; Hoffmeister M; Ludwig L; Brenner H
    JMIR Res Protoc; 2020 Apr; 9(4):e16413. PubMed ID: 32242518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Differing Invitation Models on the Uptake of Immunological Fecal Occult Blood Testing.
    Gruner LF; Hoffmeister M; Ludwig L; Meny S; Brenner H
    Dtsch Arztebl Int; 2020 Jun; 117(25):423-430. PubMed ID: 32885780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials.
    Gruner LF; Amitay EL; Heisser T; Guo F; Niedermaier T; Gies A; Hoffmeister M; Brenner H
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33806234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial.
    Schrotz-King P; Hoffmeister M; Sauer P; Schaible A; Brenner H
    JMIR Res Protoc; 2020 Aug; 9(8):e17516. PubMed ID: 32755890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invitation letters increase participation in colorectal cancer screening - results from an observational study.
    Zhan T; Hielscher T; Bilge A; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
    Z Gastroenterol; 2017 Dec; 55(12):1307-1312. PubMed ID: 29212101
    [No Abstract]   [Full Text] [Related]  

  • 7. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.
    Goldshore MA; Mehta SJ; Fletcher W; Tzanis G; Doubeni CA; Paulson EC
    Am J Prev Med; 2020 Jul; 59(1):41-48. PubMed ID: 32564804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gender-specific invitation letters on utilization of colorectal cancer screening.
    Zhan T; Hielscher T; Eckardt M; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
    Z Gastroenterol; 2019 Sep; 57(9):1051-1058. PubMed ID: 31525797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.
    Coronado GD; Rivelli JS; Fuoco MJ; Vollmer WM; Petrik AF; Keast E; Barker S; Topalanchik E; Jimenez R
    J Gen Intern Med; 2018 Jan; 33(1):72-78. PubMed ID: 29019046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Web-Based Versus Paper-Based Questionnaires and Follow-Up Strategies on Participation Rates of Dutch Childhood Cancer Survivors: A Randomized Controlled Trial.
    Kilsdonk E; van Dulmen-den Broeder E; van der Pal HJ; Hollema N; Kremer LC; van den Heuvel-Eibrink MM; van Leeuwen FE; Jaspers MW; van den Berg MH
    JMIR Cancer; 2015 Nov; 1(2):e11. PubMed ID: 28410161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Bowel Cancer: Increasing Participation via Personal Invitation.
    Hoffmeister M; Holleczek B; Zwink N; Stock C; Stegmaier C; Brenner H
    Dtsch Arztebl Int; 2017 Feb; 114(6):87-93. PubMed ID: 28266301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial.
    Brenner H; Calderazzo S; Seufferlein T; Ludwig L; Dikopoulos N; Mangold J; Böck W; Stolz T; Eisenbach T; Block T; Kopp-Schneider A; Czock D; Tikk K
    JAMA; 2019 May; 321(17):1686-1692. PubMed ID: 31063574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A targeted promotional DVD fails to improve Māori and Pacific participation rates in the New Zealand bowel screening pilot: results from a pseudo-randomised controlled trial.
    Bartholomew K; Zhou L; Crengle S; Buswell E; Buckley A; Sandiford P
    BMC Public Health; 2019 Sep; 19(1):1245. PubMed ID: 31500594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.